Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2021. Start Trial.
Date Value
June 30, 2026 -16.53M
March 31, 2026 -15.93M
December 31, 2025 -19.01M
September 30, 2025 -21.99M
June 30, 2025 -27.64M
March 31, 2025 -29.93M
December 31, 2024 -29.46M
September 30, 2024 -4.513M
June 30, 2024 -2.248M
March 31, 2024 -1.068M
Date Value
December 31, 2023 -0.7259M
September 30, 2023 -40.54M
June 30, 2023 -34.17M
March 31, 2023 -28.73M
December 31, 2022 -22.41M
September 30, 2022 -0.5575M
June 30, 2022 -0.6647M
March 31, 2022 -0.3877M
December 31, 2021 -1.070M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Abbott Laboratories --
AngioDynamics, Inc. 3.673M
Alphatec Holdings, Inc. 56.52M
AtriCure, Inc. 64.94M
Baxter International, Inc. 1.319B